to page content
to site navigation
Weighing in at 150 lbs, is Mark Pincus, frenetic visionary of Zynga. His DNA is one strand entrepreneur and one strand competitive gamer. Mark founded Tribe.net (www.tribe.net), one of the first social networks in 2003.
Prior to Tribe, he was the founder and CEO of SupportSoft (Nasdaq: SPRT), the world's leading provider of support automation software. Prior to SupportSoft, Mark co-founded Freeloader, the first consumer push information
For more than 20 years, filmmaker, music producer, and creative visionary QD3 has been producing hits and influencing culture. QD3 was born in London and raised in Stockholm, Sweden where he got his start in Hip Hop by
touring as a break-dancer. With many gold, platinum and multi-platinum albums and singles to his name, QD3's success spreads to Rap, R&B and Pop. In addition to his many hits with artists such as Tupac, Ice Cube, and L.L. Cool J, he
has composed award-winning musical scores for film and TV projects such as Menace II Society, Fresh Prince of Bel Air, and Training Day. In 1999, QD3 started a documentary production
company, QD3 Entertainment, focused on chronicling the many dimensions of urban culture, garnering both commercial success and critical acclaim for titles such as the multi-platinum selling Tupac Shakur biopic, Thug
Angel; the BEEF series; and most recently, the Lil' Wayne (Sundance) biopic, The Carter. In June 2006, QD3 went on to form QD3 Digital to take advantage of the technology explosion of broadband video, user
generated content, video on demand, and mobile platforms. In 2009, QD3 Digital will be launching two web-based entertainment properties, qd3.com and ehustle.com. Early 2010 will follow with the launch of its first XBox and PS3 video game,
Scratch: The Ultimate DJ, in partnership with Genius Products, Numark, and Akai.
Dr. Larry Brilliant is the Executive Director of Google.org, where he leads major initiatives aimed at reducing global poverty, improving the health of the least advantaged in the world, and working to halt the effects
of the climate crisis. Larry is an M.D. and M.P.H., board-certified in preventive medicine and public health. He is a founder and director of The Seva Foundation, which works in dozens of countries around the world, primarily to eliminate
preventable and curable blindness. He serves as a member of the strategic advisory committee for Kleiner Perkins (KPCB) Venture Capital and also sits on the boards of The Skoll Foundation, Health Metrics Network, Omidyar Networks Humanity
United, and InSTEDD, an organization bringing technological tools to improve disaster response. In addition to his medical career, Larry co-founded The Well, a pioneering virtual community, with Stewart Brand in 1985. He also holds a
telecommunications technology patent and has served as CEO of two public companies and other venture-backed start-ups. The author of two books and dozens of articles on infectious diseases, blindness, and international health policy, Larry
has worked at every level of government. He was recently a "first responder" for CDC's smallpox bio-terrorism response effort, volunteered in Sri Lanka for tsunami relief, and established an interdisciplinary consultancy to prepare for
possible pandemic influenza. Larry lived in India working as a United Nations medical officer for more than a decade where he played a key role in the successful World Health Organization (WHO) smallpox eradication program and has recently
worked for the WHO polio eradication effort as well. He was Associate Professor of epidemiology, global health planning and economic development at the University of Michigan. Larry earned a Masters in Public Health in health planning and
economic development from the Univ
John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels. He was previously
president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1
billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding. Prior to his eight years with BP, Mr. Melo was a
director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation. John serves on the Board of Directors for U.S. Oil,
a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer. John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of
Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Dominic Orr was named President and CEO of Aruba Networks in April 2006. Prior to that, Mr. Orr served as the company's Chairman of the Board. Previously, Dominic Orr was the president of Nortel Networks, Intelligent
Internet Web Systems. He previously served as the president and chief executive of Alteon WebSystems which was merged with Nortel Networks in Oct. 2000. Mr. Orr has more than 20 years of experience in the computer systems and communication
networking industry and has held senior positions at Bay Networks, Hewlett-Packard and Hughes Aircraft. Mr. Orr. is a member of the Sciences Board of Visitors at UCLA. He holds a BS in physics from City University of New York and a MS and
PhD from California Institute of Technology.
John Doerr joined Intel in 1974 just as they invented the famous "8080" 8 bit microprocessor. At Intel, he held various engineering, marketing and management assignments, and was one of their top-ranked sales executives.
In 1980, he joined Kleiner Perkins Caufield & Byers and sponsored a series of investments including Compaq, Cypress, Intuit, Macromedia, Netscape, Lotus, Millennium Pharmaceuticals, S3, Sun Microsystems, Amazon.com, and Symantec. John
was the founding CEO of Silicon Compilers and currently serves on the Board of Directors of Google, Intuit, Amazon.com, Homestore.com, and Sun Microsystems. His privately held company board seats include Good Technology, and Segway. He
holds patents for computer memory devices he invented as a design engineer at Monsanto. Recent interests include education, the Internet and biotechnology genomics. John was born one of five children and raised in St. Louis, Missouri. He
holds a BS and MS in Electrical Engineering from Rice University and an MBA from the Harvard Graduate School of Business Administration.
Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than forty new technology based ventures, over half of which have already become public companies. He formed the first
Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 90 Life Sciences
companies which are developing hundreds of products to treat major underserved medical needs representing huge markets in the nearly two trillion dollar healthcare sector. Brook was the founding President and then Chairman of four
biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion. He is currently on the Board of Directors of eight companies, most recently joining
CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, Nanofluidics and XDx, Inc.. He was formerly a Director of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals,
Pharmacopeia, Ligand Pharmaceuticals (Chairman), Hybritech (Chairman), Genprobe, Nanogen, and others. These companies have pioneered the medical uses of molecular biology, monoclonal antibodies, molecular diagnostics and genomics. Brook
was President and a Director of the Western Association of Venture Capitalists and is a contributing author to the book "Guide to Venture Capital". He is currently a Board member of the University of California at San Francisco Medical
Foundation, the California Healthcare Institute, the New Schools Foundation, Stanford's Bio-X Advisory Council, the Stanford Eye Council and TechNet. He is Co-Chair of the current five year, $1.4 billion, UCSF Capital Campaign. He was
formerly a Director of the Entrepreneurs Foundation, t
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
Prior to Good Technology, Mr. Shader served as a Vice President and General Manager at Amazon.com, which he joined upon the company's acquisition of Accept.com, a company he co-founded and led as CEO. Accept.com was the
first consumer-to-consumer, Internet-based, payment services provider. Mr. Shader's involvement in both Accept.com and Good Technology resulted from his two experiences as an entrepreneur-in-residence with Kleiner Perkins Caufield &
Byers and Benchmark Capital. Previously, he served as Vice President of Partner and Developer Relations at Netscape Communications Corporation, where he also built Netscape's international marketing team. Before joining Netscape, he served
as Vice President of OEM Sales and Business Development at Collabra Software, Inc., which Netscape acquired, and worked for GO Corporation, a pioneer in pen computing. Mr. Shader received a B.S. in Industrial Engineering and Operations
Research from University of California at Berkeley, and an M.B.A. from Stanford University.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
A robust online curriculum for entrepreneurs.
Explore Founders School >
A network of U.S. cities facilitating a weekly entrepreneur education program. Go to 1 Million Cups >
Whether you are starting or growing a company, FastTrac will help you live your dream at each stage.
Get started with FastTrac >